HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Feline Lymphoma

Feline Lymphoma

Feline lymphoma poses a complex challenge within veterinary oncology, warranting extensive research efforts. Investigations delve into various aspects of the disease, including its origins, progression mechanisms, and therapeutic interventions. Scientists explore potential genetic susceptibilities, environmental influences, and viral triggers such as feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). Cutting-edge imaging technologies aid in early detection, while innovative treatments like chemotherapy, radiation, and immunotherapy offer hope for better outcomes. Furthermore, clinical trials evaluate promising drugs and targeted therapies tailored specifically for feline lymphoma. Through these multifaceted endeavors, researchers aim to deepen our understanding of the condition, refine diagnostic approaches, and advance treatment modalities, ultimately enhancing the well-being of cats affected by this ailment.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp